HY

Hydromer IncOOTC HYDI Stock Report

Last reporting period 31 Mar, 2023

Updated 20 Nov, 2024

Last price

Market cap $B

0.006

Micro

Exchange

OOTC - OTC

HYDI Stock Analysis

HY

Uncovered

Hydromer Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-28/100

Low score

Market cap $B

0.006

Dividend yield

29.41 %

Shares outstanding

4.772 B

Hydromer, Inc. is a polymer research and development company. The company is headquartered in Branchburg, New Jersey. The firm operates through two segments: Industrial and Medical. The Company’s products include Medical Device Coatings, Industrial Coatings, Substrates We Coat, Hydromer Hydrogels and Sanitizer Solutions. The firm offers custom industrial and medical device coatings, contract coating services, customized coating equipment, contract manufacturing, customer service and tech support. The firm technologies deliver lubricity, thromboresistance, anti-fogging, antimicrobial and other properties. Its coatings aid in the manufacture of medical devices, aerospace components, cosmetics, and products in a variety of industries. The firm has customers in the United States of America, Europe and Asia-Pacific. The Company’s wholly owned subsidiary is Biosearch Medical Products, Inc.

View Section: Eyestock Rating